Tumor cells usually have high levels of constitutive NF-κB activity [5,328,329,330,331,332], and exposure to cytotoxic agents, including ionizing radiation, further enhances NF-κB activity [331], providing tumor cells with survival advantages and increased resistance to ionizing radiation and other cytotoxic treatments. Here, NFKB1 is linked to neoplasm.